Announcements Trials

Browse Landscape

Phase

Status

Recruiting 1 Not yet recruiting 1 Completed 1

Sponsor Class

OTHER 13 INDUSTRY 4 NIH 2 OTHER_GOV 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Urinary Bladder Neoplasms 1

Interventions

pembrolizumab 9 Drug Therapy 9 Bevacizumab 9 Radiotherapy 8 Carboplatin 8 Oxaliplatin 7 Cyclophosphamide 7 Surgical Procedures, Operative 6 Cisplatin 6 Capecitabine 6 tislelizumab 5 Paclitaxel 5 Fluorouracil 5 Docetaxel 5 Control Groups 5 Nivolumab 4 Immune Checkpoint Inhibitors 4 Gemcitabine 4 Endoscopic Mucosal Resection 4 sintilimab 3 fludarabine 3 Trastuzumab 3 Pemetrexed 3 Neoadjuvant Therapy 3 Leucovorin 3 Laparoscopy 3 Irinotecan 3 Injections 3 Hematologic Tests 3 HMPL-013 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Recruiting × OTHER_GOV × Mitomycin × Clear all

NCT06388720 2026-05-29

IMGeS

National Cancer Center, Korea

Phase 2 Recruiting

Urinary Bladder Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡